Late effects in survivors of post-transplant lymphoproliferative disease.
Mary Claire McGlynnKassidy BradyJessica M HealeyVikas R DharnidharkaA Marion YbarraJanis StollStuart C SweetRobert J HayashiPublished in: Pediatric blood & cancer (2023)
Survivors of PTLD experience LE including late mortality regardless of chemotherapy exposure. Further investigation to better understand LE could optimize upfront therapy for children with PTLD and improve outcomes.